INTRODUCTION
Hydroxyethyl starch (HES) and dextran are polysaccharide-based plasma volume expanders (PVE) which consist respectively of high molecular weight hydroxyethylglucose and glucose polymers with heterogeneous structure and properties. They are used for treatment of hypovolaemia and haemorrhage as plasma substitutes since they can significant increase plasmatic volume [14, 27] . Nowadays, therapeutic use of dextran is less common compared to HES due to the increased risk for anaphylactic shock [11] .
The use of PVEs is prohibited in sports because they can be used to prevent dehydration and because they can mask the use of erythropoietins or blood doping, since they can influence the blood passport by decreasing haemoglobin and haematocrit values [20] . For these reasons, PVEs are included by the World Anti-Doping Agency (WADA) in the Prohibited List of substances and methods [26] .
based on in-source fragmentation (isCID) to generate low mass fragment ions from the sugar backbone and can be analyzed with a "dilute-and-shoot" strategy.
HES and dextran show a complex urinary excretion profile due to their macromolecular nature. HES is available as a mixture of chemically modified glucose polymers with an average molecular weight (MW) of 130 kDa, whereas dextran products have typically an average molecular weight of 40 (DEX 40) or 70 kDa (DEX 70) [14, 19, 22] .
Since the nephron tubules only allow excretion of compounds with an MW less than 50 kDa, fractionation during urinary elimination can be observed as low MW components rapidly excreted in urine whereas high MW components are not filtered [1, 12] . Once the high MW polysaccharides are cleaved by plasma amylase into smaller oligosaccharides (≈ 200-40 000 Da), they can be excreted in urine, with a speed inversely correlated to their size [13, 17] .
In this work, the urinary excretion profiles in time of HES and dextran as a matter of doping control were investigated using the conventional isCID approach. Additionally, since detection of HES and dextran oligosaccharides in full scan mode without in source CID (FSMS) is not described yet, the latter was also investigated.
Experiments were carried out by means of ultra-high pressureliquid chromatography coupled to Orbitrap™ high resolution mass spectrometry (UHPLC-HRMS). This technology has not yet been described for the detection of polysaccharide-based PVEs. was obtained from Sigma-Aldrich (Bornem, Belgium). Internal standard solution containing 100 µg · mL -1 of HPCD was prepared in water. Gas used for the mass spectrometer was nitrogen (Alphagaz2-grade) from Air Liquide (Desteldonk, Belgium).
MATERIALS AND METHODS

Chemicals
Sample preparation
HES and dextran oligomers were obtained by hydrolysis with trifluoroacetic acid (TFA) 3M, adapting a procedure previously described by Gallego and Segura [6] . Briefly, hydrolyzed HES (10 mg · mL 
Liquid chromatography
The liquid chromatographic system was an Accela LC (Thermo Scientific, Bremen, Germany) equipped with degasser, Accela 1250 pump, autosampler thermostated at 10°C and a heated column compartment. The column employed was a Zorbax SB-C8, 2.1 x 50 mm and 1. 
High-resolution mass spectrometry
The LC effluent was pumped to an Exactive benchtop, Orbitrap™- A mass extraction window of 5 ppm was used.
Method validation
The validation was carried out following Eurachem validation guidelines [5] . Ten human urine samples, declared negative after routine doping analysis, were spiked with HES and dextran at a measurement range from 10 to 1000 µg · mL -1 . The limit of detection (LOD) was defined as the lowest level at which a diagnostic ion could be identified in all 10 urine samples with a signal-to-noise (S/N) ratio greater than 3 and a retention time difference of less than 0.3 min to the reference.
For dextran semi-quantitation, calibration curves from 10 to 1000 µg · mL -1 (10, 50, 100, 500, 1000) were used. 30 µL of in-
FIG. 1. MASS SPECTRA OF HES AND DEXTRAN IN FSMS AND ISCID MODE
ternal standard (100 µg · mL -1 ) were added. The precision of the method was checked by repeatability (intraday, n=6), intermediate precision (interday, n= 2), and reproducibility (interoperator, n= 2).
Intraday repeatability was studied by calculating the percent relative standard deviation (% relative standard deviation, RSD) for 6 determinations each of peak area of dextran (500 µg · mL -1 ) performed on the same day. The matrix effect was calculated by comparing the peak areas in reference samples, containing only water, with the peak areas of the 10 urine samples (spiked at 500 µg · mL -1 ), after analysis in triplicate.
Selectivity was tested during the validation procedure. The 10 blank urines used for determining detection capability were analyzed as described above.
Selectivity was further tested by analyzing urine samples containing common doping agents including diuretics, stimulants, β-blockers, β-agonists, narcotics, corticosteroids, anabolic steroids and non-steroidal anti-inflammatory drugs. Similarly to Kolmonen et al. [13] , also urine samples from 20 diabetics were analyzed to evaluate abnormal excretion of endogenous oligosaccharides.
Excretion samples
Excretion urine samples of HES and dextran were collected at the Ghent University Hospital during a controlled study approved by the ethical committee (EC UZG 2006/178). Two patients received 500 mL of Volulyte ® (average molecular weight: 130 kDa; molar substitution: 0.4; concentration: 6% w/v), and two patients received 500 mL of Rheomacrodex ® (average molecular weight: 40 kDa; concentration: 10% w/v), both in a 2-hour period. Samples were collected before and until 5 days after administration.
RESULTS & DISCUSSION
Mass spectrometry. The high number of molecular species originating from the in vivo hydrolysis of HES and dextran yields complex spectra with plenty of information ( Figure 1) . Investigation of the total ion current chromatograms of post-administration samples showed for HES and dextran typical ion clusters with constant m/z shifts, as already presented in previous works [3, 6, 9] . The clusters were observed in positive and in negative mode with different ion types for both PVEs, including molecular or adduct ions, in positive and negative mode. were generally higher when isCID was used (Figure 2 ). Also negative ionization was observed, as previously described by Cmelik et al. [3] , but showed less sensitivity than the positive mode.
Detection of metabolites in excreted urine in FSMS and isCID modes
As expected, a large number of metabolites were excreted in urine for both PVEs. The diagnostic ions for the metabolites covered the whole scan range. Therefore, three high-abundant ions were selected as representative for low, medium and high m/z ions and
FIG. 2. COMPARISON BETWEEN MS RESPONSE OF DIFFERENT ION TYPES FOR THE REPRESENTATIVE HES METABOLITE Glu 2 HE 1 (LEFT) AND DEXTRAN METABOLITE GLU 3 (RIGHT) IN REFERENCE STANDARD SOLUTIONS
FIG. 3. EXTRACTED ION CHROMATOGRAMS FOR HES AND DEXTRAN REPRESENTATIVE IONS SHOWING THE PRESENCE OF MULTIPLE PEAKS
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Urinary excretion of HES and dextran by UHPLC-HRMS
Total ion current, but also extracted chromatograms for dextran (Figure 3 ), showed distorted peaks with a 2-minute peak width. This is most likely due to the broad molecular weight distribution of dextran metabolites including molecules, including multiple isobaric isomers, with an MW of 1 kDa up to 50 kDa, eluting at different retention times. Additionally, the presence of a certain species is also dependent on the excretion stage.
The presence of multiple metabolite populations for both HES and dextran has been previously described [13] .
Figures 4 and 5 show chromatograms for HES and dextran in
samples from excretion studies at different post-administration times.
In the excretion samples, HES' most abundant population eluted at 2.8 min, whereas for dextran the most abundant peaks were recorded at 0.8 min (Figure 3 ).
Use of isCID yielded a higher MS response for all 6 investigated
ions. This can be explained by the fact that, in isCID mode, the same fragment can be generated by a high number of metabolites with different masses, whereas for FS acquisition only a few isomeric oligosaccharides, with identical chemical formula, contribute to the signal.
Concerning HES, most of the detected species show similar n HE / Dextran ions were all clearly detected after 3 and 12 hours, both with isCID and without isCID ( Figure 5 ). They were not detected in FS mode after 24 hours, whereas the use of isCID prolonged the detection window up to 48 hours. This is in agreement with previous work, which showed that in the 0-24 h fraction up to 5 kDa is excreted [13] and can be detected without isCID.
It can be concluded that contemporary detection in FS and isCID mode is particularly interesting since it can provide important information on the administration time. Taking into account that the duration of volume expansion is 8-12 hours for HES and 6-12 hours for dextran [22] , detection of multiple metabolites both with and without isCID can therefore discriminate whether the PVE has been administered on the same day of the doping control.
Method validation HES
For the validation, 130 kDa HES was partially hydrolyzed to yield lower molecular weight HES. This was necessary because the 130 kDa HES could not be detected without isCID because the high molecular weight species could not enter the mass spectrometer.
Validation results for HES are presented in Table 1 . Due to the presence of multiple peaks, it is very important to select the retention time window for the most abundant of them to increase sensitivity.
In this case, the peak at 2.8 min was selected.
HES showed the lowest LOD of 10 µg · mL -1 for the ion [Glu 2 HE 1 -
] + in isCID mode; this LOD is comparable to those from previous works [9, 13, 16] . A great difference was observed with FSMS where for the same ion an LOD of 500 µg · mL -1 was calculated. This difference in sensitivity has already been explained by the fact that, in isCID mode, the same fragment can be generated by 
FIG. 4. DETECTION OF THREE REPRESENTATIVE HES IONS AT DIFFERENT POST-ADMINISTRATION TIMES, WITH AND WITHOUT CID. NEGATIVE URINE AND URINE SPIKED WITH HYDROLYSED HES
(500 μg · mL (Table 1) .
No interferences were detected in blank samples, diabetics' urine or urine containing other doping agents, showing excellent selectivity of the method.
Dextran
Similar to the validation of HES, dextran with an average molecular weight of 40 kDa yielded a poor signal when analyzed without isCID. Therefore, partial hydrolysis of dextran 40 kDa was also performed.
Compared to HES, selectivity is a bigger issue for dextran because physiopathological excretion of hexose-containing oligosaccharides can theoretically generate false positive results. To solve this problem, a threshold of 500 µg · mL -1 has been proposed for screening purposes [9] . Indeed, several negative samples, analyzed with this method, showed an isCID signal from endogenous oligosaccharides with 10-100 fold lower signals than the suggested threshold ( Figure 6b ).
In FSMS mode, the molecular ion of quadruply hydroxypropylated β cyclodextrin at m/z= 1384.5685 was used for semi-quantitation, whereas the fragment ion corresponding to the dihydroxypropyl isomaltose at m/z= 441.1966 was selected.
[Glu 3 -H 2 O+H] + was selected among the numerous diagnostic ions for dextran semi-quantitation both in FSMS and isCID mode, providing the best compromise between sensitivity and linearity.
The peak at 2.7 minutes was selected for semi-quantitation since the calculated dextran concentration allowed to confirm recent administration (>500 µg · mL -1 after 12 hours), although early-eluting species are more abundant after 3 hours ( Figure 5 ). However, once a suspicious peak at 2.8 is detected, it is recommended to the analyst to check the whole elution window (0.6-2.7 min) to have further evidence before confirmation analysis.
Intraday repeatability, interday precision, and reproducibility were respectively 6.1%, 20.9% and 10.9% in the FMSM mode, and 7.1%, 9.9% and 8.3% in the isCID mode. The excretion study presented in this work confirmed that the threshold proposed by Guddat is reliable to discriminate between natural excretion of oligosaccharides and recent dextran administration (up to 12 hours). Despite the elevated concentration measured in FSMS, it was not possible to define a threshold for this acquisition mode since concentrations in negative samples were comparable to the quality control samples (Figure 6a ). Urinary excretion of HES and dextran by UHPLC-HRMS case, the reference can represent only partially the composition of dextran metabolites in urine, especially since this evolves over time.
Observing the data from excretion results, several low and medium m/z diagnostic ions showed abundant MS signals and the best detection windows and can be used to estimate dextran concentration in the sample. Since the method is for screening purposes, one of these ions can be monitored in the first instance to reveal suspicious samples, similarly as described in other high-throughput screening analyses [10] . In case a potential positive sample is detected, retrospective "post-targeted" data evaluation using multiple diagnostic ions is suggested before the necessary confirmatory analysis by partially methylated alditol acetates (PMAA) [24] or enzymatically derived isomaltose [8] .
LOD in CID was well below the suggested threshold (50 µg · mL -1 ).
Regression curves always showed R 2 > 0.90. Ion suppression in isCID was approximately 40%.
Another important issue was represented by samples from diabetic patients, which can lead to false positive results. In fact, as also described by Kolmonen et al. [13] , high amounts of oligosaccharides (> 1 mg · mL -1 ) were detected in all samples from diabetics, both in FSMS and isCID mode. Also in this case, the above-mentioned confirmation methods can be used to discriminate dextran administration.
No interferences were detected in the samples containing common doping agents.
CONCLUSIONS
Urinary excretion profiles of HES and dextran have been investigated with a "dilute-and-shoot" screening method by LC-HRMS by using different acquisition modes, investigating time-dependent detectability of HES and dextran urinary oligosaccharide metabolites in post-administration. In isCID mode, HES was detected after 72 hours, whereas dextran was present above the 500 µg · mL -1 threshold up to 12 hours. Detection of multiple metabolites without isCID is related to recent administration of the PVE (24 hours).
[ Since the instrument acquires full scan spectra, the detection of HES or dextran in a suspicious sample can be pre-confirmed by post-screening monitoring of other metabolites or diagnostic ions, providing even more robust analytical results.
